Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|---|
1 | 2 | ||||
Diplopia | Diplopia | x | x | ||
Dizziness | Dizziness | x | x | ||
Somnolence | Drowsiness | x | x | ||
Headache | Headache | x | x | ||
Haemorrhage | Haemorrhage | x | |||
Haemoglobin | Haemorrhage | x | |||
Hyperventilation | Hyperventilation | x | x | ||
Inflammation | Inflammation | x | |||
Nausea | Nausea | x | x | ||
Pain | Pain | x | x | ||
Tachycardia | Tachycardia | x | x | ||
Muscular weakness | Muscular weakness | x | |||
Agitation | Excitement | x | x | ||
Muscle necrosis | Muscle necrosis | x | |||
Vision blurred | Vision blurred | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |